• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hetrazepine PAF antagonists.

作者信息

Ikegami K, Meade C J, Heuer H O, Birke F

机构信息

Nippon Boehringer Ingelheim, Kawanishi, Japan.

出版信息

J Lipid Mediat. 1992 Jun-Jul;5(2):177-82.

PMID:1326346
Abstract

Hetrazepines such as WEB-2086 or WEB-2170 are potent, specific, competitive PAF antagonists binding at the same site as the PAF molecule. Despite their structural similarity to known hypnotic drugs they lack hypnotic actions. They almost certainly bind not only cell-surface but also intracellular PAF receptors, which may explain their activity in disease models in which adherence of neutrophils or other cell types to the vascular endothelium plays a role.

摘要

相似文献

1
Hetrazepine PAF antagonists.
J Lipid Mediat. 1992 Jun-Jul;5(2):177-82.
2
[Platelet-activating factor (PAF) antagonists].[血小板活化因子(PAF)拮抗剂]
Tanpakushitsu Kakusan Koso. 1991 Feb;36(3):379-87.
3
The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.血小板活化因子受体拮抗剂RP 59227可阻断介导豚鼠巨噬细胞和人多形核白细胞中活性氧释放的血小板活化因子受体。
J Pharmacol Exp Ther. 1991 Aug;258(2):567-75.
4
Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.使用[3H]阿帕泛(一种选择性竞争性血小板活化因子拮抗剂)对豚鼠腹腔巨噬细胞上血小板活化因子受体进行药理学特性研究:阿帕泛在功能研究中的非竞争性行为与解离动力学缓慢有关的证据。
Mol Pharmacol. 1993 Feb;43(2):302-12.
5
Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs.
Zhongguo Yao Li Xue Bao. 1992 Jul;13(4):326-9.
6
[Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].[嗜中性粒细胞和嗜酸性粒细胞中血小板活化因子(PAF)受体的特性研究]
Pneumologie. 1990 Feb;44 Suppl 1:531-2.
7
Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells.过氧化氢介导中性粒细胞黏附于培养的人内皮细胞的细胞内机制。
Microvasc Res. 1999 Mar;57(2):63-74. doi: 10.1006/mvre.1998.2117.
8
Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.贝帕泛(WEB 2170)的药理活性,一种新型选择性血小板活化因子异氮杂卓酮拮抗剂。
J Pharmacol Exp Ther. 1990 Dec;255(3):962-8.
9
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.SR 27417的生化和药理活性,一种高效、长效的血小板活化因子受体拮抗剂。
J Pharmacol Exp Ther. 1991 Oct;259(1):44-51.
10
Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.一种强效血小板活化因子拮抗剂的药理学:Ro 24 - 4736
J Pharmacol Exp Ther. 1991 Oct;259(1):78-85.

引用本文的文献

1
Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.血小板活化因子受体的核定位控制视网膜新生血管形成。
Cell Discov. 2016 Jul 12;2:16017. doi: 10.1038/celldisc.2016.17. eCollection 2016.
2
Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.维生素C可阻断吸烟产生的具有炎症性的血小板活化因子模拟物。
J Clin Invest. 1997 May 15;99(10):2358-64. doi: 10.1172/JCI119417.
3
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.
新型血小板活化因子拮抗剂UR-12633在内毒素休克啮齿动物模型中的作用
Br J Pharmacol. 1996 Jul;118(5):1223-31. doi: 10.1111/j.1476-5381.1996.tb15527.x.
4
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.卡波西肉瘤细胞在体外产生的血小板活化因子可诱导并维持体内血管生成。
J Clin Invest. 1995 Aug;96(2):940-52. doi: 10.1172/JCI118142.